Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2024, Labcorp (LH) reported revenue of $3.28 billion, up 7.4% over the same period last year. EPS came in at $3.50, compared to $3.38 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $3.26 billion, representing a surprise of +0.64%. The company delivered an EPS surprise of +0.57%, with the consensus EPS estimate being $3.48.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Labcorp performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Biopharma Laboratory Services: $737.70 million versus the four-analyst average estimate of $734.73 million. The reported number represents a year-over-year change of +2.6%. Revenues- Diagnostics Laboratories: $2.55 billion versus the four-analyst average estimate of $2.53 billion. The reported number represents a year-over-year change of +8.9%. Adjusted Operating Income- Biopharma Laboratory Services: $120.90 million versus the three-analyst average estimate of $111.44 million. Adjusted Operating Income- Diagnostics Laboratories: $387.40 million compared to the $409.56 million average estimate based on three analysts. View all Key Company Metrics for Labcorp here>>>Shares of Labcorp have returned +0.6% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Labcorp (LH): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks